S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
Log in
NYSE:LCI

Lannett Stock Forecast, Price & News

$6.08
-0.07 (-1.14 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$5.99
Now: $6.08
$6.22
50-Day Range
$5.13
MA: $5.84
$6.38
52-Week Range
$4.89
Now: $6.08
$14.72
Volume367,870 shs
Average Volume681,170 shs
Market Capitalization$244.54 million
P/E RatioN/A
Dividend YieldN/A
Beta1.6
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages. It also provides its products for various medical indications comprising cholesterol, muscle spasm, pain management, irritable bowel, antipsychosis, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, migraine, bronchospasms, and gallstone. In addition, the company manufactures active pharmaceutical ingredients. It markets its products under the Lipitor, Lioresal, Bentyl, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Concerta, Toprol-XL, Prilosec, Ditropan, Protonix, Imitrex, Brethine, and Actigall brands to generic pharmaceutical and private label distributors, drug wholesalers, chain drug retailers, mail-order pharmacies, other pharmaceutical manufacturers, managed care and health maintenance organizations, hospital buying groups, and governmental entities. The company has supply and development agreements with Jerome Stevens Pharmaceuticals, Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, and Aralez Pharmaceuticals. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Read More
Lannett logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.44 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP51601210
Phone215-333-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$545.74 million
Cash Flow$2.67 per share
Book Value$7.51 per share

Profitability

Net Income$-33,370,000.00

Miscellaneous

Employees1,020
Market Cap$244.54 million
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$6.08
-0.07 (-1.14 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lannett (NYSE:LCI) Frequently Asked Questions

How has Lannett's stock price been impacted by Coronavirus?

Lannett's stock was trading at $7.74 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LCI stock has decreased by 21.4% and is now trading at $6.08.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Lannett?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Lannett
.

When is Lannett's next earnings date?

Lannett is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Lannett
.

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) released its quarterly earnings results on Wednesday, August, 26th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.04. The company earned $137.92 million during the quarter, compared to analysts' expectations of $134.30 million. Lannett had a negative net margin of 6.11% and a positive return on equity of 14.50%. The business's revenue for the quarter was up 3.0% on a year-over-year basis. During the same period last year, the business earned $0.37 EPS.
View Lannett's earnings history
.

What guidance has Lannett issued on next quarter's earnings?

Lannett issued an update on its FY 2021 After-Hours earnings guidance on Wednesday, August, 26th. The company provided EPS guidance of for the period. The company issued revenue guidance of $520-545 million, compared to the consensus revenue estimate of $566.43 million.

What price target have analysts set for LCI?

3 equities research analysts have issued 1 year price objectives for Lannett's shares. Their forecasts range from $6.00 to $11.00. On average, they expect Lannett's share price to reach $8.50 in the next twelve months. This suggests a possible upside of 39.8% from the stock's current price.
View analysts' price targets for Lannett
.

Who are some of Lannett's key competitors?

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Celgene (CELG), Akorn (AKRX), Skechers USA (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

Who are Lannett's key executives?

Lannett's management team includes the following people:
  • Mr. Timothy C. Crew, CEO & Director (Age 58)
  • Mr. Martin P. Galvan, VP of Fin. & CFO (Age 67)
  • Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 57)
  • Mr. John M. Abt, VP & Chief Quality Operations Officer (Age 54)
  • Mr. John Kozlowski, Chief of Staff & Strategy Officer (Age 47)

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

Who are Lannett's major shareholders?

Lannett's stock is owned by many different institutional and retail investors. Top institutional investors include LSV Asset Management (5.07%), Bank of New York Mellon Corp (0.98%), Charles Schwab Investment Management Inc. (0.85%), Principal Financial Group Inc. (0.76%), Principal Financial Group Inc. (0.77%) and Jacobs Levy Equity Management Inc. (0.67%). Company insiders that own Lannett stock include Albert Paonessa III, David A Drabik, Jeffrey Farber, Patrick G Lepore and Timothy C Crew.
View institutional ownership trends for Lannett
.

Which institutional investors are selling Lannett stock?

LCI stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Russell Investments Group Ltd., LSV Asset Management, X Square Capital LLC, Prudential Financial Inc., ClariVest Asset Management LLC, Nuveen Asset Management LLC, and Phocas Financial Corp..
View insider buying and selling activity for Lannett
.

Which institutional investors are buying Lannett stock?

LCI stock was acquired by a variety of institutional investors in the last quarter, including Jacobs Levy Equity Management Inc., Engineers Gate Manager LP, Charles Schwab Investment Management Inc., Exchange Traded Concepts LLC, Virtu Financial LLC, Aigen Investment Management LP, Principal Financial Group Inc., and Principal Financial Group Inc.. Company insiders that have bought Lannett stock in the last two years include Albert Paonessa III, Jeffrey Farber, Patrick G Lepore, and Timothy C Crew.
View insider buying and selling activity for Lannett
.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $6.08.

How big of a company is Lannett?

Lannett has a market capitalization of $244.54 million and generates $545.74 million in revenue each year. The company earns $-33,370,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Lannett employs 1,020 workers across the globe.

What is Lannett's official website?

The official website for Lannett is www.lannett.com.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.